Satkunasivam et al. performed a similar analysis of SEER mPC patients treated with CRP or radiation therapy versus no local intervention, and after adjustment for several clinicopathologic variables, noted lower cancer-specific (HR 0.48) and all-cause (HR 0.43) mortality for patients treated with radical prostatectomy [6]. This evidence concerns the gene CRP and cancer.